ANXA1 and diabetes mellitus: Similar to the MAPK inhibitor annexin-1 which has shown benefit in preventing the microvascular complications of diabetes, investigators have utilized Na2S to inhibit MAPK, which dampens NETosis with a corresponding acceleration in wound healing (122).